The growing demand for precise immunological research and therapeutic design has spurred significant progress in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently generated using diverse expression systems, including bacterial hosts, higher cell lines, and insect transcription pl